EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
1-Year Return
51.18%
This Quarter Return
+14.93%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$5.49B
AUM Growth
-$310M
(-5.3%)
Cap. Flow
-$175M
Cap. Flow
% of AUM
-3.19%
Top 10 Holdings %
Top 10 Hldgs %
20.85%
Holding
223
New
43
Increased
76
Reduced
62
Closed
19
Top Buys
| 1 |
GE Vernova
GEV
|
$82.1M |
| 2 |
DT Midstream
DTM
|
$59.8M |
| 3 |
Cheniere Energy
LNG
|
$50.8M |
| 4 |
Workday
WDAY
|
$50.6M |
| 5 |
RB Global
RBA
|
$47.2M |
Top Sells
| 1 |
Idexx Laboratories
IDXX
|
$95.2M |
| 2 |
Waste Connections
WCN
|
$85.6M |
| 3 |
Trane Technologies
TT
|
$80.7M |
| 4 |
D.R. Horton
DHI
|
$56.9M |
| 5 |
Rollins
ROL
|
$54.3M |
Sector Composition
| 1 | Healthcare | 37.19% |
| 2 | Technology | 20.42% |
| 3 | Industrials | 16.23% |
| 4 | Consumer Discretionary | 7.92% |
| 5 | Energy | 5.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
NiSource
NI
$18.7B
| $12.2M | 0.22% |
+331,555
| New | +$12.2M |
|
127
Cytokinetics
CYTK
$6B
| $12M | 0.22% |
254,148
| – | – |
|
128
Cabot Corp
CBT
$4.34B
| $11.5M | 0.21% |
126,317
+3,497
| +3% | +$319K |
|
129
Relay Therapeutics
RLAY
$695M
| $11.1M | 0.2% |
2,682,083
| – | – |
|
130
Avidity Biosciences
RNA
$6.23B
| $10.9M | 0.2% |
375,924
| – | – |
|
131
Procept Biorobotics
PRCT
$2.21B
| $10.1M | 0.18% |
124,874
-4,126
| -3% | -$332K |
|
132
Rocket Pharmaceuticals
RCKT
$351M
| $9.69M | 0.18% |
770,691
| – | – |
|
133
Gartner
IT
$18.1B
| $9.46M | 0.17% |
+19,531
| New | +$9.46M |
|
134
S&P Global
SPGI
$165B
| $8.78M | 0.16% |
17,622
+563
| +3% | +$280K |
|
135
Dynavax Technologies
DVAX
$1.17B
| $8.6M | 0.16% |
673,810
| – | – |
|
136
Linde
LIN
$221B
| $8.4M | 0.15% |
20,066
+1,258
| +7% | +$527K |
|
137
Dell
DELL
$86.1B
| $8.27M | 0.15% |
71,827
-15,214
| -17% | -$1.75M |
|
138
Lexeo Therapeutics
LXEO
$271M
| $8.13M | 0.15% |
1,234,834
-621,152
| -33% | -$4.09M |
|
139
Synovus
SNV
$7.29B
| $8.11M | 0.15% |
158,279
+25,019
| +19% | +$1.28M |
|
140
Manhattan Associates
MANH
$12.8B
| $8.1M | 0.15% |
29,960
+22,261
| +289% | +$6.02M |
|
141
Bruker
BRKR
$4.55B
| $7.95M | 0.14% |
135,635
+4,792
| +4% | +$281K |
|
142
Dyne Therapeutics
DYN
$1.9B
| $7.83M | 0.14% |
332,277
| – | – |
|
143
NVIDIA
NVDA
$4.06T
| $7.24M | 0.13% |
53,788
+9,425
| +21% | +$1.27M |
|
144
Home Depot
HD
$416B
| $6.95M | 0.13% |
17,856
+7,421
| +71% | +$2.89M |
|
145
Broadcom
AVGO
$1.65T
| $6.7M | 0.12% |
+28,777
| New | +$6.7M |
|
146
Quanterix
QTRX
$202M
| $6.54M | 0.12% |
+615,000
| New | +$6.54M |
|
147
ServiceNow
NOW
$189B
| $6.19M | 0.11% |
5,837
+285
| +5% | +$302K |
|
148
Nektar Therapeutics
NKTR
$674M
| $6.18M | 0.11% |
443,333
-183,334
| -29% | -$2.56M |
|
|
INZY
149
DELISTED
Inozyme Pharma
INZY
| $6.15M | 0.11% |
2,220,000
-1,914,436
| -46% | -$5.3M |
|
150
American Express
AXP
$230B
| $6.07M | 0.11% |
+20,446
| New | +$6.07M |
|